Ploidy Level and Tumor Progression in Prostatic Carcinoma

References

• Eneroth C M, Zetterberg A. Microspectrophotometric DNA analysis of malignant salivary gland tumors. Acta Otolaryngol 1974; 77: 289–94
   PubMed Web of Science ®Google Scholar
• Eneroth C-M, Zetterberg A. The relationship between the nuclear DNA content in smears of aspirates and the prognosis of mucoepidermoid carcinoma. Acta Otolaryngol 1975; 80: 429–33
   PubMed Web of Science ®Google Scholar
• Zetterberg A, Esposti PL. Prognostic significance of nuclear DNA levels in prostatic carcinoma. Scand J Urol Nephrol 1980; 55: 53–8
   Google Scholar
• Auer G, Zetterberg A. The prognostic significance of nuclear DNA content in malignant tumors of breast prostate and cartilage. Adv Clin Cytol 1984; 2: 123–34
   Google Scholar
• Zetterberg A, Esposti PL. Cytophotometric DNA-analysis of aspirated cells from prostatic carcinoma. Acta Cytol 1976; 20: 46–57
   PubMedGoogle Scholar
• Zetterberg A, Auer G. Ploidy level and grade of malignancy in some solid tumors. UCLA Symp Genes Cancer 1984; 59–67
   Google Scholar
• Auer G, Caspersson T, Wallgren A. DNA content and survival in mammary carcinoma. Anal Quant Cytol 1980; 3: 161–5
   Google Scholar
• Ewers S B, Långström E, Baldetorp B, Killander D. Flow-cytometric DNA analysis in primary breast carcinomas and clinic-pathological correlations. Cytometry 1984; 5: 408–19
   PubMedGoogle Scholar
• Kreicbergs A, Söderberg G, Zetterberg A. The prognostic significance of nuclear DNA content in chonrosarcoma. Anal Quant Cytol J 1980; 4: 271–8
   Google Scholar
• Moberger B, Auer G, Forsslund G, Moberger G. The prognostic significance of DNA measurements in endometrial carcinoma. Cytometry 1984; 5: 430–6
   PubMedGoogle Scholar
• Böcking A. Reproduzierbares zytologisches Malignitätsgradung des Prostatakarzinomas. Akt Urol 1981; 12: 278–82
   Google Scholar
• Tribukait B, Rönström L, Esposti P-L. Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostatic carcinoma. Anal Quant Cytol J 1983; 5: 107–11
   PubMedGoogle Scholar
• Kreicbergs A, Zetterberg A. Cytophotometric DNA measurements of chondrosarcoma. Analyt Quant Cytol J 1980; 2: 84–92
   PubMedGoogle Scholar
• Forsslund G, Zetterberg A. A quantitative evaluation of cytophotometric DNA analysis in retrospective studies using archival tumor specimens. Analyt Quant Cytol Histol 1990; 12: 259–66
   PubMedGoogle Scholar
• Forsslund G, Zetterberg A. Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Analyt Quant Cytol Histol 1990; 50(50)4281–5
   Google Scholar
• Decosse J J, Eiello N. Feulgen hydrolysis: Effect of acid and temperature. J Histochem Cytochem 1966; 14: 601–4
   PubMed Web of Science ®Google Scholar
• Esposti PL. Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. Scand J Urol Nephrol 1971; 5: 199–209
   PubMedGoogle Scholar
• Esposti PL. Punctional cytologic malignancy grading at prostate cancer. Nord Med 1967; 78: 1308, in Swedish
   Google Scholar
• Esposti P L, Franzén S, Zajicek K. The aspiration biopsy smear. Diagnostic cytology and its histopathologic bases2nd ed, L G Koss. Lippincott, Philadelphia 1968; 565–96
   Google Scholar
• UICC International Union Against Cancer. TNM Classification of Malignant Tumours, P Hermanek, LH Sobin. Springer-Verlag. 1987
   Google Scholar
• Adams LR. A photographic cytophotometric method which avoids distributional error. Acta Cytol 1968; 12: 3–8
   PubMed Web of Science ®Google Scholar
• Statistical Abstract of Sweden 1987. Norstedts Tryckeri, Stockholm 1986
   Google Scholar
• Segi M. Institute of Cancer Epidemiology: Age-adjusted death rates for cancer of selected sites (a classification) in 46 countries in 1978. February, 1984
   Google Scholar
• Lundberg S, Carstensen J, Rundquist I. DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study. Cancer Res 1987; 47: 1973–7
   PubMed Web of Science ®Google Scholar
• Nemoto R, Uchida K, Shimazui T, Hattori K, Koiso K, Harada M. Immunocytochemical deornonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma. J Urol 1989; 141: 337–40
   PubMedGoogle Scholar
• Danova M, Riccardi A, Gaetani P, et al. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol 1988; 24: 873–80
   PubMedGoogle Scholar
• Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. Adv Clin Cytol 1984; 2: 163–89
   Google Scholar
• Wilson G D, McNally N J, Dische S, et al. Measurements of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988; 58: 423–31
   PubMed Web of Science ®Google Scholar